According to the comprehensive guidelines proposed by the American Association for the Study of Liver Diseases in 2021, the main indications for the use of albumin solutions in patients with cirrhosis are large-volume puncture, acute kidney injury, hepatorenal syndrome, and spontaneous bacterial peritonitis [36]. This evidence concerns the gene ALB and hepatorenal syndrome.